Federal contract award
75A50124C00046
LICENSE PATHOGEN REDUCTION TECHNOLOGY (PRT) FOR RED BLOOD CELL (RBC) COMPONENTS TO REDUCE THE RISK OF TRANSFUSION-TRANSMITTED INFECTION (TTI) BY RECOGNIZED, EMERGING, EPIDEMIC, AND ENDEMIC PATHOGENS THAT IS CAPABLE OF TREATING OVER 10 MILLION RBC COM
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | BARDA - ASPR / DAAPPO / BARDA DCMA |
| NAICS | 541714 — Research and Development in Biotechnology (except Nanobiotechnology) |
| PSC | 6505 — Drugs and Biologicals |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | COST SHARING |
| Obligations | $65.4M |
| Current contract value | $65.4M |
| Potential contract value / ceiling | $209.0M |
| Start date | Sep 30, 2024 |
| Current end date | Sep 30, 2031 |
| Potential end date | Sep 30, 2031 |
| Latest award activity | Jul 21, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 4 of 4 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Jul 21, 2026 | P00003 | $33.2M | SUPPLEMENTAL FUNDING TO THE BASE PERIOD (CLIN 0001, CLIN 0002 & CLIN 0003); EXERCISE OPTION 1 (CLIN 0004); UPDATE TRAVEL BUDGET; UPDATE GO/NO-GO MILESTONES; UPDATE INDIRECT RATES; UPDATE COA THRESHOLD TO $350,000; INCORPORATE MANDATORY CLAUSES AS |
| Mar 24, 2025 | P00002 | $0 | CERUS - NO-COST MODIFICATION IS TO UPDATE ARTICLE G.2. CONTRACTING OFFICER TO ADD JULIE BERGMANN AS THE ALTERNATE CONTRACTING OFFICER'S REPRESENTATIVE (ACOR), UPDATE ARTICLE G.7 INDIRECT COST RATES, AND UPDATE CONTRACT CLAUSES PER EXECUTIVE ORDE |
| Jan 21, 2025 | P00001 | $0 | NO-COST MODIFICATION IS TO UPDATE ARTICLE G.1. CONTRACTING OFFICER TO REFLECT RICHARD A. HALL AS THE CONTRACTING OFFICER. |
| Sep 20, 2024 | 0 | $32.1M | LICENSE PATHOGEN REDUCTION TECHNOLOGY (PRT) FOR RED BLOOD CELL (RBC) COMPONENTS TO REDUCE THE RISK OF TRANSFUSION-TRANSMITTED INFECTION (TTI) BY RECOGNIZED, EMERGING, EPIDEMIC, AND ENDEMIC PATHOGENS THAT IS CAPABLE OF TREATING OVER 10 MILLION RBC COM |
Estimated positioning window
Sep 30, 2030 – Mar 30, 2031
50/100
Why this recompete signal
Contract timing and recorded acquisition signals at the time of calculation.
Stored score: 50/100. Available recorded signals: 45 points.
- Contract end 2031-09-30 (1794 days from calculation)
- +5 points
- 25 historical awards in this buyer and category group
- +15 points
- 4 recorded award transactions
- +10 points
- Latest award action: 2026-07-21
- +5 points
- Parent award identifier recorded
- +0 points
- Solicitation identifier recorded
- +10 points
- Linked official forecast
- +0 points
- Calculated on
- 2026-11-01 10:17:53.997580+00:00
The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.
Rule-based research score; it does not measure your chance of winning.
This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.
Recompete score calculated Nov 1, 2026.
Buyer contacts from matching notices
Matched on exact award/solicitation identifier and awarding agency. Source dates describe the notice, not current contact verification.
| Contact | Role | Published contact methods | Evidence | Source date |
|---|---|---|---|---|
| BARDA-BAA@hhs.gov | Contact | BARDA-BAA@hhs.gov | Source | Mar 20, 2026 |
| BARDA-BAA@hhs.gov | Contact | BARDA-BAA@hhs.gov | Source | Mar 19, 2026 |
| BARDA-BAA@hhs.gov | Contact | BARDA-BAA@hhs.gov | Source | May 29, 2025 |
| BARDA-BAA@hhs.gov | Contact | BARDA-BAA@hhs.gov | Source | Dec 18, 2024 |
| BARDA-BAA@hhs.gov | Contact | BARDA-BAA@hhs.gov | Source | May 31, 2024 |
| BARDA-BAA@hhs.gov | Contact | BARDA-BAA@hhs.gov | Source | Apr 23, 2024 |
| BARDA-BAA@hhs.gov | Contact | BARDA-BAA@hhs.gov | Source | Mar 29, 2024 |
| BARDA-BAA@hhs.gov | Contact | BARDA-BAA@hhs.gov | Source | Dec 22, 2023 |
| BARDA-BAA@hhs.gov | Contact | BARDA-BAA@hhs.gov | Source | Nov 9, 2023 |
| BARDA-BAA@hhs.gov | Contact | BARDA-BAA@hhs.gov | Source | Sep 26, 2023 |
Research next steps
- Check the linked forecast or SAM for a confirmed solicitation and current timing.
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.